001     917482
005     20230224084256.0
024 7 _ |a 10.1021/acs.molpharmaceut.1c00926
|2 doi
024 7 _ |a 1543-8384
|2 ISSN
024 7 _ |a 1543-8392
|2 ISSN
024 7 _ |a 35559658
|2 pmid
024 7 _ |a WOS:000810650800016
|2 WOS
037 _ _ |a FZJ-2023-00695
082 _ _ |a 610
100 1 _ |a Castillo, Stuart R.
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Probing the Link between Pancratistatin and Mitochondrial Apoptosis through Changes in the Membrane Dynamics on the Nanoscale
260 _ _ |a Washington, DC
|c 2022
|b American Chemical Society
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1673942949_26809
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Pancratistatin (PST) is a natural antiviral alkaloid that has demonstrated specificity toward cancerous cells and explicitly targets the mitochondria. PST initiates apoptosis while leaving healthy, noncancerous cells unscathed. However, the manner by which PST induces apoptosis remains elusive and impedes the advancement of PST as a natural anticancer therapeutic agent. Herein, we use neutron spin-echo (NSE) spectroscopy, molecular dynamics (MD) simulations, and supporting small angle scattering techniques to study PST's effect on membrane dynamics using biologically representative model membranes. Our data suggests that PST stiffens the inner mitochondrial membrane (IMM) by being preferentially associated with cardiolipin, which would lead to the relocation and release of cytochrome c. Second, PST has an ordering effect on the lipids and disrupts their distribution within the IMM, which would interfere with the maintenance and functionality of the active forms of proteins in the electron transport chain. These previously unreported findings implicate PST's effect on mitochondrial apoptosis.
536 _ _ |a 5244 - Information Processing in Neuronal Networks (POF4-524)
|0 G:(DE-HGF)POF4-5244
|c POF4-524
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Rickeard, Brett W.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a DiPasquale, Mitchell
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Nguyen, Michael H. L.
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Lewis-Laurent, Aislyn
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Doktorova, Milka
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Kav, Batuhan
|0 P:(DE-Juel1)178946
|b 6
700 1 _ |a Miettinen, Markus S.
|0 0000-0002-3999-4722
|b 7
700 1 _ |a Nagao, Michihiro
|0 0000-0003-3617-251X
|b 8
700 1 _ |a Kelley, Elizabeth G.
|0 0000-0002-6128-8517
|b 9
700 1 _ |a Marquardt, Drew
|0 0000-0001-6848-2497
|b 10
|e Corresponding author
773 _ _ |a 10.1021/acs.molpharmaceut.1c00926
|g Vol. 19, no. 6, p. 1839 - 1852
|0 PERI:(DE-600)2132489-X
|n 6
|p 1839 - 1852
|t Molecular pharmaceutics
|v 19
|y 2022
|x 1543-8384
856 4 _ |u https://juser.fz-juelich.de/record/917482/files/acs.molpharmaceut.1c00926.pdf
909 C O |o oai:juser.fz-juelich.de:917482
|p VDB
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-Juel1)178946
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-524
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Molecular and Cellular Information Processing
|9 G:(DE-HGF)POF4-5244
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-12
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-12
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MOL PHARMACEUT : 2021
|d 2022-11-12
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b MOL PHARMACEUT : 2021
|d 2022-11-12
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IBI-7-20200312
|k IBI-7
|l Strukturbiochemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)IBI-7-20200312
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21